Difference between revisions of "Pharm Tech Minutes 2019.04.11"

From IHE Wiki
Jump to: navigation, search
(9:35 - 10:30 Work-item "Adverse Event Reporting (ADER)" Part 1)
(9:35 - 10:30 Work-item "Adverse Event Reporting (ADER)" Part 1)
Line 50: Line 50:
 
* We should continue to look for funding for example through Universities and or European funding.
 
* We should continue to look for funding for example through Universities and or European funding.
 
* Try to get HL7 Europe interested ( Catherine Chronaki).
 
* Try to get HL7 Europe interested ( Catherine Chronaki).
* Some countries are already experimenting with adverse events for example [https://developer.nhs.uk/apis/itk3tocedischarge-2-5-0/explore_allergies_and_adverse_reactions.html| UKproject]
+
* Some countries are already experimenting with adverse events for example [https://developer.nhs.uk/apis/itk3tocedischarge-2-5-0/explore_allergies_and_adverse_reactions.html | UKproject]
 
* The FHIR resource itself is not mature ( level 0). The Patient Care workgroup have a biweekly telephone conference on Thursday's 5 pm EST on this topic.
 
* The FHIR resource itself is not mature ( level 0). The Patient Care workgroup have a biweekly telephone conference on Thursday's 5 pm EST on this topic.
* IHE Pharmacy will continue to pursue to find interested parties and for funding of this project.  
+
* IHE Pharmacy will continue to pursue to find interested parties and for funding of this proj ect.  
 
* The Adverse Event and Edverse Event reporting are tightly related and are important for the pharmaco vigilance.
 
* The Adverse Event and Edverse Event reporting are tightly related and are important for the pharmaco vigilance.
  

Revision as of 03:19, 11 April 2019

Meeting minutes

WebEx details:

Join IHE Pharmacy's WebEx meeting

Wed., April 10th at Thurs., April 11th, 2019, 9:00.... | 9 am

Paris (Europe Summer GMT + 02: 00)

Organizer: Conferentiefaciliteit

[1]

Meeting Number: 234 934 563

Password : This meeting is not protected by a password.

audio connection

+ 44-203-478-5289 UK Domestic Toll

Access code: 234 934 563


You need numbers or additional information? See international phone numbers .


Minutes

09:30 - 09:35 Welcome

  • Participants
    • Stephane Spahni
    • Esther Peelen
    • Jacqueline Surugue
    • Michael Tan
    • Marc Robberecht
    • Jose Costa Teixeira
    • Leonidas Tzimis

9:35 - 10:30 Work-item "Adverse Event Reporting (ADER)" Part 1

  • Funding has not been succesful. Lareb has sent in a pitch, but the Dutch government did not reward it with a funding.
  • EMA has their focus on IDMP and look at the IHE proposal as a responsibility of each country.
  • We should continue to look for funding for example through Universities and or European funding.
  • Try to get HL7 Europe interested ( Catherine Chronaki).
  • Some countries are already experimenting with adverse events for example | UKproject
  • The FHIR resource itself is not mature ( level 0). The Patient Care workgroup have a biweekly telephone conference on Thursday's 5 pm EST on this topic.
  • IHE Pharmacy will continue to pursue to find interested parties and for funding of this proj ect.
  • The Adverse Event and Edverse Event reporting are tightly related and are important for the pharmaco vigilance.

10:30 - 11:00 --- Coffee break ---

11:00 - 12:30 Medication Information Sharing

  • Strategic discussion on IDMP, Medication knowledge and supporting HL7 resources
  • International Board asked us to think about IDMP
  • Understanding the influence of IDMP
  • EU Horizon 2020 project: "Upscaling the global identification of medicines"


12:30 - 13:00 --- Lunch ---

13:00 - 15:15 Supply topics Part 1

  • Review current status
  • Define work items, schedule and next steps
  • Scope
  • Priorities
  • Work-item members
  • Plans and strategies on uptake


15:15 - 15:45 --- Coffee break ---

15:45 - 16:45 Supply topics Part 2

  • Continue work
  • Work on Technical Supplement


16:45 - 17:00 Any other business

17:00 - Adjourn

Pharmacy Technical Committee